<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Exafs Study of Pt anticancer drugs in cells and tissues</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Sergey</forename><surname>Nikitenko</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Annette</forename><surname>Rompel</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">University of Vienna</orgName>
								<address>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ana</forename><surname>Mijovilovich</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">University of Utrecht</orgName>
								<address>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Alina</forename><surname>Nemirovski</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">Hebrew University of Jerusalem</orgName>
								<address>
									<country key="IL">Israel</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Dan</forename><surname>Gibson</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">Hebrew University of Jerusalem</orgName>
								<address>
									<country key="IL">Israel</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Exafs Study of Pt anticancer drugs in cells and tissues</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">99861B97A117A53E41CEA5642C8D44E6</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-22T20:00+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Aims of the experiment and scientific background</head><p>Cisplatin, cis-diamminedichloroplatinum(II) is among the most important chemotherapeutic agents ever developed. It is a critical component of therapeutic regimens in abroad range of malignancies <ref type="bibr" target="#b0">[1]</ref>. However, despite an inordinate amount of work, more than three decades after its clinical introduction, the exact mechanism of cisplatin action on tumor cells is not fully understood. It is commonly accepted that cisplatin kills the cancer cell by binding covalently and essentially irreversibly to the nuclear DNA. The binding occurs in the major groove of the DNA where the two cis chloride ligands are replaced by two N7 atoms of two adjacent guanines on the same strand of the DNA. This distortion of the DNA triggers cellular responses that in favorable cases end in the induction of apoptosis <ref type="bibr" target="#b1">[2]</ref>. It is noteworthy that only approximately 1% of the cellular platinum ends up bound to the nuclear DNA. Yet, nearly 99% of the research efforts have been directed to studying all aspects of Pt-DNA lesions. Since the Pt-DNA adducts formed in different types of cancer cells are expected to be the same, why then is cisplatin very effective against some types of cancer (testicular, ovarian) and totally ineffective against others (colon, breast). It might be due to the adducts that the drug forms with the non-DNA cellular components, which account for 99% of the cellular Pt. Very little is known about these interactions and most of the information pertaining to the mechanism of action is derived from simplistic aqueous model inorganic chemistry. Based on model studies, and basic inorganic chemistry, it is expected that most of the cellular cisplatin will bind to sulfur containing ligands and especially to glutathione (GSH), a thiol containing tripeptide that exists in mM concentrations. There is one report claiming that 60% of the cellular platinum is bound to GSH <ref type="bibr" target="#b2">[3]</ref>. Yet, in recent [1H, 15N] 2D NMR studies that we conducted by labeling cisplatin with 15 N ammine ligands, and monitoring the interactions with aqueous extracts of cancer cells, contrary to expectations, we were unable to detect any sulfur binding to cisplatin. This might be due to certain limitation of NMR spectroscopy, which would make it impossible to observe signals of cisplatin</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>bound to large biopolymers. The interaction of cellular sulfur with Pt anticancer agents is believed to play a major role, and could serve to either inactivate the Pt drugs (mainly due to binding to thiols) or to activate drugs such as carboplatin (by binding to thioether). Results EXAFS L3 Pt spectra were collected for all samples at BM26A beamline (ESRF). Samples of cells, cell extracts and mice treated tumors were measured. Samples were placed in Kapton sealed holders and kept frozen at all times. Measurements were performed at 15K using a cryostat and data was collected using a multielement Ge solid-state detector. XANES spectra of the Pt L3 edge of therapeutically relevant Pt(II) and Pt(IV) (powder) complexes (cisplatin and oxaliplatin) were collected. The XANES spectra of solids containing varying proportions of Pt(II) and Pt(IV) complexes in 10 % steps were collected to determine whether it was possible to correlate the known proportions with the XANES edge features, as a tool for monitoring reduction of Pt(IV) in complex systems. The XANES spectra of Pt(II) and Pt(IV) differ in the height of their edges, with Pt(IV) being substantially higher. Based on the pure Pt(IV) and Pt(II) model compounds a linear relationship has been made. This is the basis for biological samples and will allow us to determine effectively the relative proportions of each oxidation state present in the biological material. To monitor the cellular reduction of Pt(IV) complexes in mouse cancer cells, the cells were treated with the Pt(IV) complexes: ct-[Pt(NH3)2(OH)2(oxal)] and ct-[Pt(NH3)2(OAc)2(oxal)] at a concentration of 100 µM. From height of the edge it can be concluded that 37 % reduction to Pt(II) has been occurred (see Fig. <ref type="figure">2</ref>). The results obtained in March 2008 proved the feasibility of the experiments in cells (mouse). XANES of two compounds with sulfur bound to Pt, show a shoulder at 11577 eV, that differ from the oxaliplatin models (see Fig. <ref type="figure">3</ref>). Sulfur coordination in mouse cells is highly unlikely.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1 (</head><label>1</label><figDesc>Fig. 1 (left): XANES spectra of Pt(II) Pt(IV) complexes and XANES on mouse cells. Fig. 2 (middle): Peak height ratio extracted from Pt(IV)/Pt(II) standard mixtures (circles), a linear fit (line), and results for a mouse sample (triangle). Fig. 3. XANES of oxaliplatin and complexes C6H18N2PtS2 and C12H24PtS4.</figDesc><graphic coords="2,198.83,130.00,198.43,153.31" type="bitmap" /></figure>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Current Status of Platinum-Based Antitumor Drugs</title>
		<author>
			<persName><forename type="first">Ernest</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Christen</forename><forename type="middle">M</forename><surname>Giandomenico</surname></persName>
		</author>
		<idno type="DOI">10.1021/cr980420v</idno>
	</analytic>
	<monogr>
		<title level="j">Chemical Reviews</title>
		<title level="j" type="abbrev">Chem. Rev.</title>
		<idno type="ISSN">0009-2665</idno>
		<idno type="ISSNe">1520-6890</idno>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="2451" to="2466" />
			<date type="published" when="1999-08-17">1999</date>
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Wong, E., Giandomenico, C.M. Chem. Rev. 1999. 99 (9) 2451-2466.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Cellular processing of platinum anticancer drugs</title>
		<author>
			<persName><forename type="first">Dong</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Stephen</forename><forename type="middle">J</forename><surname>Lippard</surname></persName>
		</author>
		<idno type="DOI">10.1038/nrd1691</idno>
	</analytic>
	<monogr>
		<title level="j">Nature Reviews Drug Discovery</title>
		<title level="j" type="abbrev">Nat Rev Drug Discov</title>
		<idno type="ISSN">1474-1776</idno>
		<idno type="ISSNe">1474-1784</idno>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="307" to="320" />
			<date type="published" when="2005-03-24">2005</date>
			<publisher>Springer Science and Business Media LLC</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Wang, D., Lippard, S.J. Nature Reviews Drug Discovery. 2005, 4, 307-320.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance.</title>
		<author>
			<persName><forename type="first">T</forename><surname>Ishikawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ali-Osman</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0021-9258(20)80702-9</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<title level="j" type="abbrev">Journal of Biological Chemistry</title>
		<idno type="ISSN">0021-9258</idno>
		<imprint>
			<biblScope unit="volume">268</biblScope>
			<biblScope unit="issue">27</biblScope>
			<biblScope unit="page" from="20116" to="20125" />
			<date type="published" when="1993-09">1993</date>
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Ishikawa, T., Ali-Osman, F. J. Biol. Chem. 1993. 268 (27), 20116-20125.</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">XANES Determination of the Platinum Oxidation State Distribution in Cancer Cells Treated with Platinum(IV) Anticancer Agents</title>
		<author>
			<persName><forename type="first">Matthew</forename><forename type="middle">D</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Garry</forename><forename type="middle">J</forename><surname>Foran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mei</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Philip</forename><forename type="middle">J</forename><surname>Beale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Trevor</forename><forename type="middle">W</forename><surname>Hambley</surname></persName>
		</author>
		<idno type="DOI">10.1021/ja0354770</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of the American Chemical Society</title>
		<title level="j" type="abbrev">J. Am. Chem. Soc.</title>
		<idno type="ISSN">0002-7863</idno>
		<idno type="ISSNe">1520-5126</idno>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="issue">25</biblScope>
			<biblScope unit="page" from="7524" to="7525" />
			<date type="published" when="2003-05-30">2003</date>
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Hall, M.D., Foran, G.J., Zhang,M., Beale, P.J.,and Hambley, T.W. JACS. 2003, 125, 7524-7525.</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">A</forename><surname>Rompel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Meyer-Klauke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mijovilovich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Eichinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jakupec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Keppler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Inorg. Chem</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>Suppl. 1, S15</note>
	<note type="raw_reference">Rompel, A., Meyer, T., Meyer-Klauke, W., Mijovilovich, A., Eichinger, R., Jakupec, M., Keppler, B.K. J. Biol. Inorg. Chem. 2007. 12, Suppl. 1, S15.</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">DNA interactions of new cytotoxic tetrafunctional dinuclear platinum complex trans,trans-[{PtCl2(NH3)}2(piperazine)]</title>
		<author>
			<persName><forename type="first">Viktor</forename><surname>Brabec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Petros</forename><surname>Christofis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Martina</forename><surname>Slámová</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Hana</forename><surname>Kostrhunová</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Olga</forename><surname>Nováková</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Yousef</forename><surname>Najajreh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dan</forename><surname>Gibson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jana</forename><surname>Kašpárková</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bcp.2007.03.003</idno>
	</analytic>
	<monogr>
		<title level="j">Biochemical Pharmacology</title>
		<title level="j" type="abbrev">Biochemical Pharmacology</title>
		<idno type="ISSN">0006-2952</idno>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1887" to="1900" />
			<date type="published" when="2007-06">2007</date>
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Brabec, V.; Christofis, P.; Slamova, M.; Kostrhunova, H.; Novakova, O.; Najajreh, Y.; Gibson, D.; Kagparkova, J. Biochemical Pharmacology 2007, 73, (12), 1887-1900.</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Cationic Nonsymmetric Transplatinum Complexes with Piperidinopiperidine Ligands. Preparation, Characterization, in Vitro Cytotoxicity, in Vivo Toxicity, and Anticancer Efficacy Studies</title>
		<author>
			<persName><forename type="first">Yousef</forename><surname>Najajreh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Elena</forename><surname>Khazanov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Seba</forename><surname>Jawbry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Yael</forename><surname>Ardeli-Tzaraf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jose</forename><forename type="middle">Manuel</forename><surname>Perez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jana</forename><surname>Kasparkova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Viktor</forename><surname>Brabec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Yechezkel</forename><surname>Barenholz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dan</forename><surname>Gibson</surname></persName>
		</author>
		<idno type="DOI">10.1021/jm060237r</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Medicinal Chemistry</title>
		<title level="j" type="abbrev">J. Med. Chem.</title>
		<idno type="ISSN">0022-2623</idno>
		<idno type="ISSNe">1520-4804</idno>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="4665" to="4673" />
			<date type="published" when="2006-06-28">2006</date>
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Najajreh, Y.; Khazanov, E.; Jawbry, S.; Ardeli-Tzaraf, Y.; Perez, J. M.; Kasparkova, J.; Brabec, V.; Barenholz, Y.; Gibson, D. Journal of Medicinal Chemistry 2006, 49, (15), 4665-4673.</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Interactions of Platinum Complexes Containing Cationic, Bicyclic, Nonplanar Piperidinopiperidine Ligands with Biological Nucleophiles</title>
		<author>
			<persName><forename type="first">Yousef</forename><surname>Najajreh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Yael</forename><surname>Ardeli-Tzaraf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jana</forename><surname>Kasparkova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Pavla</forename><surname>Heringova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dmitri</forename><surname>Prilutski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Liliana</forename><surname>Balter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Seba</forename><surname>Jawbry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Elena</forename><surname>Khazanov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jose</forename><forename type="middle">Manuel</forename><surname>Perez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Yechezkel</forename><surname>Barenholz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Viktor</forename><surname>Brabec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dan</forename><surname>Gibson</surname></persName>
		</author>
		<idno type="DOI">10.1021/jm060238j</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Medicinal Chemistry</title>
		<title level="j" type="abbrev">J. Med. Chem.</title>
		<idno type="ISSN">0022-2623</idno>
		<idno type="ISSNe">1520-4804</idno>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="4674" to="4683" />
			<date type="published" when="2006-06-28">2006</date>
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Najajreh, Y.; Ardeli-Tzaraf, Y.; Kasparkova, J.; Heringova, P.; Prilutski, D.; Balter, L.; Jawbry, S.; Khazanov, E.; Perez, J. M.; Barenholz, Y.; Brabec, V.; Gibson, D. Journal of Medicinal Chemistry 2006, 49, (15), 4674-4683.</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">The trans labilization of cis-[PtCl2(13CH3NH2)2] by glutathione can be monitored at physiological pH by [1H,13C] HSQC NMR</title>
		<author>
			<persName><forename type="first">Dan</forename><surname>Gibson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Yonit</forename><surname>Kasherman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dina</forename><surname>Kowarski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Inna</forename><surname>Freikman</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00775-005-0064-7</idno>
	</analytic>
	<monogr>
		<title level="j">JBIC Journal of Biological Inorganic Chemistry</title>
		<title level="j" type="abbrev">J Biol Inorg Chem</title>
		<idno type="ISSN">0949-8257</idno>
		<idno type="ISSNe">1432-1327</idno>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="179" to="188" />
			<date type="published" when="2006">2006</date>
			<publisher>Springer Science and Business Media LLC</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Gibson, D.; Kasherman, Y.; Kowarski, D.; Freikman, I. Journal of Biological Inorganic Chemistry 2006, 11, 179-188.</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Mass spectrometric studies of the formation and reactivity of &lt;i&gt;trans&lt;/i&gt;‐[PtCl&lt;sub&gt;2&lt;/sub&gt;(Am)(piperidinopiperidine)] · HCl complexes with ubiquitin</title>
		<author>
			<persName><forename type="first">Liliana</forename><surname>Balter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dan</forename><surname>Gibson</surname></persName>
		</author>
		<idno type="DOI">10.1002/rcm.2244</idno>
	</analytic>
	<monogr>
		<title level="j">Rapid Communications in Mass Spectrometry</title>
		<title level="j" type="abbrev">Rapid Comm Mass Spectrometry</title>
		<idno type="ISSN">0951-4198</idno>
		<idno type="ISSNe">1097-0231</idno>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">24</biblScope>
			<biblScope unit="page" from="3666" to="3672" />
			<date type="published" when="2005-11-14">2005</date>
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Balter, L.; Gibson, D. Rapid Communications in Mass Spectrometry 2005, 19, (24), 3666-3672.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
